Skip to content

Expressive Writing for Cancer Survivors

Expressive Writing for Resilience in Adult Cancer Survivors.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04171609
Enrollment
14
Registered
2019-11-21
Start date
2019-07-19
Completion date
2020-05-14
Last updated
2020-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Survivors

Brief summary

The purpose of this study is to determine whether a 1-day expressive writing intervention for adult cancer survivors improves resilience scores as measured by the Connor-Davidson Resilience Scale (CD-RISC).

Detailed description

The purpose of this study is to determine whether a 1-day expressive writing intervention for adult cancer survivors improves resilience scores as measured by the Connor-Davidson Resilience Scale (CD-RISC).

Interventions

BEHAVIORALExpressive writing

During this daylong expressive writing workshop intervention, the writing instructor coached participants through a series of simple writing exercises. Participation required neither any prior writing experience, nor any desire to become a writer. The practices cultivate natural abilities to express the ideas that define who you are and how you experience your life.

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have ever received a cancer diagnosis * Have completed cancer treatment (e.g., surgery, radiation, or chemotherapy) * Are able to speak, read, write, and understand English * Are cognitively able to provide consent * Are able to travel to Durham to participate in the 1-day writing intervention

Exclusion criteria

-Cancer diagnosis was skin cancer that did not require additional treatment after surgical removal

Design outcomes

Primary

MeasureTime frameDescription
Change in resilience as measured by the Connor-Davidson Resilience ScaleBaseline, 6 monthsThis 25-item scale addresses resilience, and has been studied in a variety of populations. Resilience is considered as the capacity to overcome adversity.

Secondary

MeasureTime frameDescription
Post-writing survey1 day (collected during the 1-day intervention)This five-question survey is used after each writing exercise to measure how respondents reflect on their writing. This survey asks participants to respond to the first four questions using a 10-point Likert-type scale endorsing the degree to which each item reflects their thoughts and feeling about their writing. The fifth question asks for a free-response reflection on how they think and feel about how their writing went.
Change in quality of life as measured by the Quality of Life Patient/Cancer Survivor Version (QOL-CSV)Baseline, 6 monthsThe QOL-CSV is a 41-item ordinal scale measuring quality of life as a cancer patient that originated in use for pain research and was recently adapted for use in long-term cancer survivorship. This survey asks participants to measure their quality of life in terms of the physical, psychological, social, and spiritual dimensions of well-being.
Change in perceived stress as measured by Perceived Stress Scale (PSS-10)Baseline, 6 monthsThe PSS-10 is a well-known 10-item questionnaire used to evaluate responders' perceptions about their level of stress and their ability to cope with stress over the last month. Results from this questionnaire have demonstrated acceptable levels of validity and reliability. This inventory asks participants to respond using a 10-point Likert-type scale when endorsing the degree to which each item best reflects their thoughts and feelings within the past month.
Change in depression as measured by Center for Epidemiological Studies Depression Scale Revised (CESD-R)Baseline, 6 monthsThe 20-item CESD-R is one of the most common screening tests that measures depressive feelings and behaviors within the past week.
Qualitative follow-up questionnaire6 monthsThis qualitative follow-up questionnaire will be administered 6 months after the study intervention to capture participants' reflections on their experience in the study.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026